ARCHIVES

FDA Simplifies Reporting Of Adverse Events

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification

March 26, 1976

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005